SynthesisBlood2017

Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531.

Erin M Guest et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.